Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal Function
Clinical trial NCT03318809 · COMPLETED
Trial details
- NCT number
- NCT03318809
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-12
- Primary completion
- 2018-03-12
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.